Financial News
Articles published by Innovation Pharmaceuticals Inc.
![](https://storage.googleapis.com/accesswire/logos/subaccounts/28286.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/28286.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/28286.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/28286.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/28286.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/28286.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/28286.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/28286.jpg?v=0)
Innovation Pharmaceuticals Provides Brilacidin Program Update
November 18, 2021
Via AccessWire
Exposures
COVID-19
Tickers
IPIX
![](https://storage.googleapis.com/accesswire/logos/subaccounts/28286.jpg?v=0)
Via AccessWire
Tickers
IPIX
![](https://storage.googleapis.com/accesswire/logos/subaccounts/28286.jpg?v=0)
Innovation Pharmaceuticals Announces Topline Results from Phase 2 Clinical Trial of Brilacidin for COVID-19
November 11, 2021
Via AccessWire
Topics
Death
Tickers
IPIX
![](https://storage.googleapis.com/accesswire/logos/subaccounts/28286.jpg?v=0)
Database Lock Completed for Innovation Pharmaceuticals' Phase 2 Clinical Trial of Brilacidin for COVID-19
November 03, 2021
Via AccessWire
Exposures
COVID-19
Tickers
IPIX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.